Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10A
NM
Basal B
ICRF-193
TOP2
TOP
11056.151
uM
inf
0.04801
0.5349 0.5474 2.0247 0.2393
0.9850
3.0292
MCF 10A
NM
Basal B
IKK16
IKK
NFKB
7485.093
uM
3.30420
4.07620
-0.4760 -0.4790 3.2002 0.3287
0.9978
3.5766
MCF 10A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7484.09
uM
27.63420
39.63650
-0.7365 -0.7394 2.5167 0.3858
0.9956
2.6525
MCF 10A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7483.091
uM
48.69320
62.71530
-0.5328 -0.5357 2.8774 0.2858
0.9976
3.0465
MCF 10A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7485.092
uM
45.48520
59.9910
-0.5636 -0.5671 2.7388 0.2889
0.9987
3.6408
MCF 10A
NM
Basal B
Ispinesib
KSP
Kinesin
7484.067
uM
0.23564
3.81680
-0.7056 -1.0000 0.3945 0.4557
0.8684
2.7060
MCF 10A
NM
Basal B
Ispinesib
KSP
Kinesin
7483.067
uM
0.03317
0.03696
-0.6323 -0.1358 2.2198 0.5611
0.8844
3.2893
MCF 10A
NM
Basal B
Ispinesib
KSP
Kinesin
7485.067
uM
0.14987
1.80190
-0.4694 -0.8167 0.3894 0.4872
0.9420
3.7597
MCF 10A
NM
Basal B
Ixabepilone
TUBB
TUBB
7484.094
uM
0.00437
0.04204
-0.7526 -0.8693 0.4448 1.2063
0.9147
2.6561
MCF 10A
NM
Basal B
Ixabepilone
TUBB
TUBB
7483.095
uM
0.0160
0.11519
-0.8965 -0.9405 0.5360 0.8532
0.9476
2.6732
MCF 10A
NM
Basal B
Ixabepilone
TUBB
TUBB
7485.095
uM
0.02889
0.21398
-0.5677 -0.7205 0.4457 0.7050
0.9677
3.6625
MCF 10A
NM
Basal B
JNK-IN-5A
JNK
JNK
11056.144
uM
19.54620
154.7090
-0.0990 -1.0000 0.5311 0.1869
0.7972
2.8424
MCF 10A
NM
Basal B
L-779450
BRAF
MAPK
11056.149
uM
17.45540
44.1580
0.1958 -0.9043 1.1127 0.0672
0.9888
2.9204
MCF 10A
NM
Basal B
Lapatinib
EGFR/HER2
ErbB
7484.098
uM
inf
inf
0.9819 0.9819 0.0000 0.0183
0.3261
2.6137
MCF 10A
NM
Basal B
Lapatinib
EGFR/HER2
ErbB
7483.098
uM
inf
6.76260
0.9078 0.8513 0.5088 0.0205
0.9339
3.1224
MCF 10A
NM
Basal B
Lapatinib
EGFR/HER2
ErbB
7485.098
uM
7.85490
5.83020
0.3398 0.3231 3.4858 0.0601
0.9946
3.3725
MCF 10A
NM
Basal B
LBH589
HDAC
HDAC
11056.154
uM
0.19038
0.33191
-0.5925 -0.5986 1.4162 0.5725
0.9985
2.9341
MCF 10A
NM
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11056.154
uM
1.11180
5.18750
-0.6144 -1.0000 0.7133 0.3656
0.9875
2.9341
MCF 10A
NM
Basal B
Mebendazole
12944.174
uM
5.09360
7.17890
-0.0457 -0.1840 0.9131 0.2211
0.9985
2.7985
MCF 10A
NM
Basal B
Methotrexate
DHFR
Metabolism
7483.084
uM
inf
inf
0.9515 0.9515 0.0000 0.0312
-0.0222
3.2830
MCF 10A
NM
Basal B
Methotrexate
DHFR
Metabolism
7485.085
uM
inf
0.00667
0.5314 0.5163 5.0000 0.4051
0.9118
3.6369
MCF 10A
NM
Basal B
Methotrexate
DHFR
Metabolism
7484.084
uM
0.05274
0.04202
0.4113 0.3396 4.9999 0.4544
0.9346
2.6217
MCF 10A
NM
Basal B
Methylglyoxal
13551.184
uM
680.90370
999.99950
-0.2926 -0.2104 0.9138 0.3902
0.9470
3.0171
MCF 10A
NM
Basal B
MG-132
Proteasome
Proteasome
14215.189
uM
inf
inf
-0.0224 -0.0224 0.0000 0.5675
0.5599
3.3654
MCF 10A
NM
Basal B
MG-132
Proteasome
Proteasome
14215.189
uM
inf
inf
-0.0224 -0.0224 0.0000 0.5675
0.5599
3.3654